Welcome to our dedicated page for Healthcare Triangle news (Ticker: HCTI), a resource for investors and traders seeking the latest updates and insights on Healthcare Triangle stock.
Healthcare Triangle Inc (HCTI) provides healthcare IT solutions through cloud services, data science, and digital transformation platforms. This page aggregates official company news and analysis for stakeholders tracking its role in modernizing healthcare infrastructure.
Access timely updates on earnings reports, regulatory compliance milestones, and strategic partnerships. Investors will find press releases detailing product launches, managed service expansions, and initiatives supporting hospitals, payors, and life sciences organizations.
All content is curated to meet investor needs for decision-ready information while maintaining strict compliance with financial disclosure standards. Bookmark this page for centralized access to HCTI’s latest developments in healthcare interoperability and secure data management solutions.
Healthcare Triangle, Inc. (HCTI) has announced that it does not hold any cash or maintain accounts at Silicon Valley Bank (SVB), nor does it have any business relationship with SVB. This clarification comes amidst broader market concerns regarding SVB’s financial stability. HCTI is a provider of cloud solutions and data analytics for the healthcare sector, emphasizing its HITRUST Certification for data protection. The company expresses confidence in its technology and industry expertise, aimed at aiding healthcare providers in improving health outcomes.
Healthcare Triangle (Nasdaq: HCTI) has successfully assisted Floyd County Medical Center (FCMC) in implementing the MEDITECH Expanse platform. FCMC, a 25-bed critical access hospital in Iowa, transitioned from a hybrid EHR system to a unified digital solution. The project involved digitizing both paper and electronic records and modernizing workflows in clinical, billing, and financial systems.
Healthcare Triangle's consultants provided essential support to avoid errors and ensure successful outcomes. The MEDITECH Expanse implementation has enabled FCMC to improve patient care, facilitate timely care decisions, and enhance overall efficiency.
Healthcare Triangle, Inc (HCTI) reported a 48% revenue increase in Q3 2022, achieving $11.9 million compared to $8.1 million in the same period last year. The gross margin stood at 29%, with R&D costs of $1.5 million. The company raised $6.5 million via private placement and launched services in Singapore. Despite the growth, HCTI posted a net loss of $2.3 million or $(0.06) per share, while cash on hand was $4.1 million as of September 30, 2022.
Healthcare Triangle Inc. (Nasdaq: HCTI) has unveiled its services aimed at integrating Metaverse technologies into healthcare and life sciences. The market for Metaverse in healthcare is projected to reach USD 5.3 Billion by 2030, with a 48.3% CAGR. This initiative promises to enhance patient care through digital twins, real-time monitoring, and virtual engagements. HCTI's cloud-based platforms will support the implementation of these technologies, positioning the company favorably in the evolving healthcare landscape.
Healthcare Triangle has successfully implemented new functionality in MEDITECH Expanse for Chronic Care Management (CCM) at Lane Regional Medical Center. This initiative aims to enhance patient care for chronic conditions and improve value-based reimbursement.
With expert assistance from HCTI, Lane Regional transitioned from manual tracking to a streamlined process, resulting in improved efficiency, automated billing, and reduced administrative burdens. The project was completed in just four weeks, significantly enhancing care management capabilities.
Healthcare Triangle Inc. (Nasdaq: HCTI) announced that its Chairman and CEO, Suresh Venkatachari, will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. The presentation is scheduled for September 14 at 1:30 PM EDT, accompanied by one-on-one meetings with investors.
Healthcare Triangle focuses on leveraging technology to enhance healthcare outcomes for providers, payers, and life sciences organizations. The company has achieved HITRUST Certification for its Cloud and Data Platform, bolstering its commitment to data protection and security.
Healthcare Triangle Inc. (Nasdaq:HCTI) announced that its CEO, Suresh Venkatachari, will present at the 148th National Investment Banking Association (NIBA) conference on September 8, 2022, at Margaritaville Hollywood Beach Resort, Florida. The presentation will be followed by one-on-one meetings with investors. Healthcare Triangle specializes in enhancing healthcare through technology, achieving HITRUST Certification for its Cloud and Data Platform. The NIBA has a rich history of supporting the small-cap investment community, having hosted numerous investment conferences.
Healthcare Triangle (HCTI) has launched operations in Singapore, committing up to USD 25 million and creating over 500 jobs in the next five years. The company aims to enhance digital healthcare in the Asia Pacific region, which is expected to reach USD 100 billion by 2025. As a premier partner of major cloud services, Healthcare Triangle will leverage its expertise to support healthcare providers in their digital transformation journey. The digital health market in APAC is projected to grow from USD 40.3 billion in 2021 to USD 326.7 billion by 2030.
Healthcare Triangle (HCTI) announced the closing of a private placement with an institutional investor, issuing 6,097,561 shares of common stock at $1.066 each, generating approximately $6.5 million in gross proceeds. The transaction includes unregistered preferred investment options to purchase the same number of shares. Proceeds will be employed for working capital and general corporate purposes. H.C. Wainwright & Co. acted as the placement agent. The securities are offered under Section 4(a)(2) of the Securities Act and are subject to resale registration with the SEC.
Healthcare Triangle Inc. (HCTI) announced a definitive agreement for a private placement, issuing 6,097,561 shares of common stock at a price of $1.066 per share, aiming to raise approximately $6.5 million. The placement involves unregistered investment options for the same number of shares, exercisable after six months. H.C. Wainwright & Co. is the exclusive placement agent. Proceeds will be used for working capital and corporate purposes. The transaction is set to close around July 13, 2022, subject to customary conditions.
